Persistent URL of this record https://hdl.handle.net/1887/3181178
In Collections
This item can be found in the following collections:
A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1
- All authors
- Roestenberg, M.; Walk, J.; Boor, S.C. van der; Langenberg, M.C.C.; Hoogerwerf, M.A.; Janse, J.J.; Manurung, M.; Yap, X.Z.; Garcia, A.F.; Koopman, J.P.R.; Meij, P.; Wessels, E.; Teelen, K.; Waardenburg, Y.M. van; Vegte-Bolmer, M. van de; Gemert, G.J. van; Visser, L.G.; Ven, A.J.A.M. van der; Mast, Q. de; Natasha, K.C.; Abebe, Y.; Murshedkar, T.; Billingsley, P.F.; Richie, T.L.; Sim, B.K.L.; Janse, C.J.; Hoffman, S.L.; Khan, S.M.; Sauerwein, R.W.
- Date
- 2020-05-20
- Journal
- Science Translational Medicine
- Volume
- 12
- Issue
- 544